Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 09 - 01 tags : Injection save search
Revance Announces Publication of Results on Static Glabellar Lines With Repeated Treatment of DaxibotulinumtoxinA for Injection From the SAKURA Clinical Program in Dermatologic Surgery
Published: 2021-09-01 (Crawled : 13:15) - biospace.com/
RVNC | $3.66 0.55% 0.68% 740
|
Health Technology
|
| O: -0.15%
H: 1.57%
C: 1.31%
treatment injection results
Merck and Ridgeback Biotherapeutics Announce Initiation of Pivotal Phase 3 MOVe-AHEAD Study Evaluating Molnupiravir for Post-Exposure Prophylaxis of COVID-19 Infection
Published: 2021-09-01 (Crawled : 12:00) - biospace.com/
MRK | $126.88 -0.05% 0.17% 83K
|
Health Technology
|
| O: -0.09%
H: 0.76%
C: -0.05%
covid phase 3 iot molnupiravir injection infections
U.S. Government Exercises Option to Purchase Additional RAPIVAB® (peramivir injection) from BioCryst for Delivery to Strategic National Stockpile
Published: 2021-09-01 (Crawled : 11:00) - globenewswire.com
BCRX | News | $4.38 -0.68% -0.8% 3.6M
|
Health Technology
|
| O: -0.19%
H: 1.95%
C: 1.64%
injection liver
Gainers vs Losers
| 73% | 27% |
Top 10 Gainers
YSG | $4.09 4.07% 30K
|
Manufacturing
YMM | $8.45 3.55% 210K
|
Transportation and Warehousing
ABNB | $164.76 2.37% 130K
|
Administrative and Support and ...
ZTO | $20.72 2.37% 87K
|
Transportation
ZS | $179.5 1.46% 34K
|
Technology Services
Z | $43.93 0.69% 28K
|
Technology Services
ZM S | $61.88 0.42% 56K
|
Technology Services
ZUO 4 | $9.76 0.1% 21K
|
Technology Services
ZG | $43.15 -0.07% 5.9K
|
Technology Services
ZTS | $149.41 -0.1% 220K
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.